SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 95 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $91,000 | -55.0% | 95,000 | -44.1% | 0.00% | -50.0% |
| Q1 2022 | $202,000 | -63.5% | 170,000 | 0.0% | 0.00% | -60.0% |
| Q4 2021 | $554,000 | +140.9% | 170,000 | +410.5% | 0.01% | +233.3% |
| Q4 2019 | $230,000 | -33.5% | 33,300 | 0.0% | 0.00% | -40.0% |
| Q3 2019 | $346,000 | +12.3% | 33,300 | 0.0% | 0.01% | +25.0% |
| Q2 2019 | $308,000 | -54.0% | 33,300 | -54.6% | 0.00% | -50.0% |
| Q1 2019 | $670,000 | +82.6% | 73,300 | +11.2% | 0.01% | +60.0% |
| Q4 2018 | $367,000 | -64.1% | 65,900 | -23.3% | 0.01% | -50.0% |
| Q3 2018 | $1,023,000 | +16.6% | 85,900 | 0.0% | 0.01% | +11.1% |
| Q2 2018 | $877,000 | -32.2% | 85,900 | -13.8% | 0.01% | -35.7% |
| Q1 2018 | $1,294,000 | – | 99,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
| Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
| Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
| Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
| EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
| Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
| AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
| Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
| Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |